NPPA Price-Control Measure for 137 Anti-Cancer Medicines | Trade Margin Rationalisation |

The National Pharmaceutical Pricing Authority (NPPA) has notified a price-control measure aimed at making anti-cancer medicines more affordable in India.

Question: What price-control measure was notified by the NPPA for 137 anti-cancer medicines?

Answer: Trade Margin Rationalisation (TMR).

The measure caps trade margins for the identified non-scheduled anti-cancer medicines at 30% of the price to the retailer, helping limit the final prices paid by patients. The actual reduction in retail prices depends on the medicine’s existing price structure.

Key Facts for Exams:

Authority: National Pharmaceutical Pricing Authority (NPPA)

Sector: Pharmaceuticals and healthcare

Measure: Trade Margin Rationalisation (TMR)

Purpose: Improve affordability and access to anti-cancer medicines

📚 Useful for UPSC, SSC, Banking, Railway and other competitive examinations.

Follow Current Affairs Studio for daily current affairs, government policies, economy updates and exam-focused GK quizzes.

#NPPA #AntiCancerMedicines #PriceControl #CurrentAffairs2026 #CurrentAffairsStudio

NPPA price control, 137 anti cancer medicines, Trade Margin Rationalisation, TMR anti cancer drugs, National Pharmaceutical Pricing Authority, anti cancer medicine prices India, cancer treatment affordability, pharmaceutical price control India, medicine pricing policy, healthcare current affairs 2026, government health initiatives, Department of Pharmaceuticals, current affairs October 2026, daily current affairs, GK quiz, UPSC current affairs, SSC GK, banking awareness, railway exam preparation, competitive exams, Current Affairs Studio